No previous studies used ROC curves to discuss the significance of PD-L1+CD20+ % and PD-1+CD20+ % in distinguishing between healthy controls and patients with DLBCL and discriminating newly diagnosed patients from healthy volunteers. Here, PDCD1 is linked to diffuse large B-cell lymphoma.